tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Mereo Biopharma Group Plc: Buy Rating Maintained Amid Challenges and Promising Study Outcomes
PremiumRatingsMereo Biopharma Group Plc: Buy Rating Maintained Amid Challenges and Promising Study Outcomes
30d ago
Promising Outlook for Mereo Biopharma’s Setrusumab Amid Phase 3 Trial Advances and Market Potential
Premium
Ratings
Promising Outlook for Mereo Biopharma’s Setrusumab Amid Phase 3 Trial Advances and Market Potential
30d ago
Closing Bell Movers: Ultragenyx slumps 25% on UX143 recommendation
Premium
The Fly
Closing Bell Movers: Ultragenyx slumps 25% on UX143 recommendation
1M ago
Mereo BioPharma management to meet with BTIG
PremiumThe FlyMereo BioPharma management to meet with BTIG
2M ago
Buy Rating for Mereo Biopharma Group Plc: Strategic Positioning and Promising Developments in Osteogenesis Imperfecta Treatment
Premium
Ratings
Buy Rating for Mereo Biopharma Group Plc: Strategic Positioning and Promising Developments in Osteogenesis Imperfecta Treatment
3M ago
Positive Outlook for Mereo Biopharma Group Plc: Buy Rating Supported by Promising Lead Programs and Strong Financial Position
Premium
Ratings
Positive Outlook for Mereo Biopharma Group Plc: Buy Rating Supported by Promising Lead Programs and Strong Financial Position
3M ago
Mereo Biopharma Group Plc: Strong Phase II Results and Strategic Initiatives Reinforce Buy Rating
PremiumRatingsMereo Biopharma Group Plc: Strong Phase II Results and Strategic Initiatives Reinforce Buy Rating
3M ago
Mereo BioPharma sees cash runway into 2027
Premium
The Fly
Mereo BioPharma sees cash runway into 2027
3M ago
Mereo BioPharma reports Q1 EPS (2c), consensus (1c)
Premium
The Fly
Mereo BioPharma reports Q1 EPS (2c), consensus (1c)
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100